1 |
Anti-cd3 |
Muromonab |
[1] D05092 D05092 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [2] 96, 97 💬 |
2 |
Anti-cd3 monoclonal antibody |
Muromonab |
[1] D05092 D05092 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [2] 96, 97 💬 |
3 |
Ni-0401 (anti-cd3 mab) |
Muromonab |
[1] D05092 D05092 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [1] 96 💬 |